Breaking News

IQVIA Partners with AstraZeneca

Supports development of potential COVID-19 vaccine.

By: Contract Pharma

Contract Pharma Staff

IQVIA has announced a collaboration with AstraZeneca to accelerate development of a potential new vaccine for COVID-19. This joint initiative is part of the U.S. government’s recently announced Operation Warp Speed project.   Operation Warp Speed is part of a broader strategy to accelerate the development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics.   The IQVIA and AstraZeneca collaboration will drive faster delivery of clinical studies in the U.S. aimed at...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters